News

US FDA listing of Trajan’s hemaPEN blood microsampling device

US FDA listing of Trajan’s hemaPEN blood microsampling device

Trajan Scientific and Medical (Trajan) has listed its hemaPEN® blood microsampling device with the U.S. Food and Drug Administration (US FDA) as Class I for therapeutic and in vitro diagnostic (IVD) use.

This follows the hemaPEN’s recent registration in May for supply in the EU and UK as a General IVD; as well as inclusion in the TGA’s ARTG (Australian Register of Therapeutic Goods) in February as a Class I IVD.

This enables hemaPEN to be used to collect blood microsamples for clinical trials, diagnostics and applications to monitor health.

hemaPEN provides a convenient sampling procedure for collection and storage of four dried blood spot (DBS) samples. Unlike conventional DBS sampling tools, hemaPEN enables collection of an accurate and precise fixed micro-volume and is designed to maintain sample integrity for quantitative analysis. An easy-to-use sophisticated microsampling tool in the hands of non-analysts.

Remote microsampling facilitates more flexible blood sampling compared to traditional phlebotomy (blood draw) for scientific and clinical communities, for rapid R&D and implementation of new healthcare solutions for the public.

Trajan believes in science that benefits people – creating portable and affordable measurement solutions, enabling accurate results to inform preventative healthcare.

Visit www.hemapen.com to purchase or learn more about hemaPEN, and to sign up for updates.

To learn more about Trajan’s microsampling technologies and capabilities visit www.trajanscimed.com/microsampling.

Also in news

News Trajan Scientific and Medical receives ISO 13485 certification
Trajan Scientific and Medical receives ISO 13485 certification

Trajan Scientific and Medical has obtained the ISO 13485:2016 certification at both its Ringwood headquarters and Penang, Malaysia site. This certification marks a testa...

News Bridging the HDX gap with Monash and Trajan
Bridging the HDX gap with Monash and Trajan

Monash University has recently implemented Trajan's HDX Extended System within its Proteomics and Metabolomics Platform (MPMP), forging a collaborative effort aimed at n...

News Trajan collaborates with University of Melbourne's Faculty of Science on Student Industry Projects
Trajan collaborates with University of Melbourne's Faculty of Science on Student Industry Projects

Since 2017, Trajan Scientific and Medical has supported 12 industry projects with The University of Melbourne's Faculty of Science, in the Master of Biotechnology and Master of Data Science degrees.